Artiva Biotherapeutics, Inc. (ARTV) Shareholders’ equity 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) shareholders’ equity at each fiscal year-end, per SEC filings.
$110.0MFY2025 · since FY2023: -$162.0M → $110.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $110.0M | -41.1% |
| FY2024 | $186.6M | +215.2% |
| FY2023 | -$162.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice